Synbiosis, a Cambridge-based manufacturer of automated microbiological systems, has supplied a tenth ProtoCOL automated colony counting and zone sizing system to an unnamed top ten pharma company.
The ProtoCOL systems, sited at the company’s vaccine unit in Germany, are being used to speed up testing of pneumococcal and flu vaccines.
The latest system is being integrated into a GMP facility alongside eight other ProtoCOL systems and will be used to accelerate manufacturing of pneumococcal vaccines by automatically counting surviving S. pneumoniae colonies post OPKA assay.
The final ProtoCOL system is being used in the research laboratories to automate measuring the size of inhibition zones on SRD plates, which determine the efficacy of novel flu vaccines.
Elke Hearn, md of Meintrup DWS Laborgerate, Synbiosis’ German distributor, said: ‘We installed the first ProtoCOL in this major pharma company in 2001 and since then the productivity of its vaccine testing has significantly increased and its vaccines are reaching the market more rapidly.’
Synbiosis
T +44 1223 727125
F +44 1223 727101